IL116656A - 4-Amino-1, 3, 3a, 4, 7, 7a- hexahydroisoindole compounds - Google Patents

4-Amino-1, 3, 3a, 4, 7, 7a- hexahydroisoindole compounds

Info

Publication number
IL116656A
IL116656A IL11665692A IL11665692A IL116656A IL 116656 A IL116656 A IL 116656A IL 11665692 A IL11665692 A IL 11665692A IL 11665692 A IL11665692 A IL 11665692A IL 116656 A IL116656 A IL 116656A
Authority
IL
Israel
Prior art keywords
amino
hexahydroisoindole
tetrahydrofuran
methyl
isoindole
Prior art date
Application number
IL11665692A
Other versions
IL116656A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4120646A external-priority patent/DE4120646A1/en
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL116656A0 publication Critical patent/IL116656A0/en
Publication of IL116656A publication Critical patent/IL116656A/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Indole Compounds (AREA)

Description

Ui>NHN iTnVpn-a7,7, ,a3,3>l-^>>3N- JiiaiMJi 4-Amino-l,3,3a,4,7,7a-hexahydroisoindole compounds Bayer Aktiengesellschaft C.100390 in which R and R' denote hydrogen or methyl.
These compounds are useful as intermediates for preparing the pharmaceutically active derivatives which are described and claimed in Israel patent specification No. 102261, from which this application is divided.
The following examples are used as a non-limiting illustration of the invention.
Example A 4-Methylamino- 1 , 3 , 3a , 4 , 7 , 7a-hexahydroisoindole Method I: 14.4 g (60 mmol) of 70 % strength 1- ( tert . -butyloxy-carbonylamino ) -1 , 3-butadiene [J. Org. Chem. 43., 2164 (1978)], as a solution in 30 ml of absolute tetrahydro- furan, are added dropwise to 10.1 g (60 mmol) of N-tri-methylsilylmaleimide [J. Org. Chem. 4.0, 24 (1975)] in 30 ml of absolute tetrahydrofuran, which have been initially introduced into the reaction vessel. When the exothermic reaction has subsided, the mixture is boiled under reflux cooling for a further hour.
The cooled reaction mixture is then added dropwise, under nitrogen, to 7.6 g (0.2 mol) of lithium aluminium hydride in 200 ml of absolute tetrahydrofuran, which have been initially introduced into the reaction vessel. The mixture is then boiled under reflux cooling for 14 hours. 7.6 g of water in 23 ml of tetrahydrofuran, 7.6 g of 10 % strength sodium hydroxide solution and 22.8 g of water are then added dropwise in succession to the cooled reaction mixture. The salts are filtered off and the filtrate is concentrated in vacuo. The residue (10.3 g) is distilled at 87eC/0.8 mbar. 1 The distillate is taken up in 80 ml of absolute pentane, the mixture is filtered and the product is crystallised by cooling to -70 °C.
Yield: 3.3 g, melting point: 72 - 82 eC.
Treatment with an eguimolar amount of 2N hydrochloric acid gives 4-methylamino-l,3,3a,4,7/7a-hexahydro-iso-indole dihydrochloride of melting point 265-268 °C (from methanol ) .
Method II: a) 4 - ( t ert . - Buty loxyc arbony1 amino )-l,3-dioxo- 1 , 3 , 3a , 4 , 7 , 7a-hexahydroisoindole 48.0 g (0.5 mol) of maleimide are initially introduced into the reaction vessel as a solution in 200 ml of absolute tetrahydrofuran, and 120 g (0.5 mol) of approximately 70 % strength l-(tert.- butyloxycarbonylamino) -1 , 3-butadiene are added dropwise as a solution in 500 ml of absolute tetrahydrofuran, the temperature being kept at 20 to 30 eC. The mixture is subsequently stirred overnight at room temperature. It is then concentrated and the residue is recrystallised from ethyl acetate. 57 g of product having a melting point of 177 to 182 °C are obtained. A further 13 g of melting point 158 to 160 °C are obtained from the mother liquor. b) 4-Methylamino-l , 3,33,4,7, 7a-hexahydroisoindole 27.1 g (0.71 mol) of lithium aluminium hydride in 300 ml of absolute tetrahydrofuran are initially introduced into the reaction vessel, under nitrogen, and a solution of 57 g (0.21 mol) of 4-(tert.- butyloxycarbonylamino ) -1 , 3-dioxo-l , 3 , 3a , 4 , 7 , 7a- hexahydroisoindole in 570 ml of absolute tetrahydro- furan is added dropwise. The mixture is then boiled under reflux cooling overnight. After cooling, 27.1 g of water in 82 ml of tetrahydrofuran, 27.1 g of 10 % strength sodium hydroxide solution and 81.3 g of water are added dropwise to the batch in succession. The salts are filtered off with suction and washed with tetrahydrofuran and the filtrate is concentrated in vacuo. The residue is distilled under a high vacuum.
Yield: 19.1 g Example B 4-Amino-1 , 3 , 3a , 4 , 7 , 7a-hexahvdro-isoindole 13.3 g (50 mmol) of 4-tert.-butyloxycarbonylaraino-l,3-dioxo-l,3,3a,4,7,7a-hexahydro-isoindole (from Example A, method II) are stirred in 166 ml of trifluoroacetic acid at room temperature overnight. The trifluoroacetic acid is then distilled off under 10 mbar and the residue is freed from residues of acid at 50° under a high vacuum. It is then taken up in absolute tetrahydrofuran and the mixture is concentrated in vacuo. The residue is taken up in 100 ml of absolute tetrahydrofuran and the mixture is added dropwise to a solution of 11.3 g (0.3 mol) of lithium aluminium hydride in 300 ml of absolute tetrahydrofuran, under nitrogen. The mixture is then boiled under reflux cooling for 16 hours. After cooling, 11.3 g of water in 34 ml of tetrahydrofuran, 11.3 ml of 10 % strength sodium hydroxide solution and 34 ml of water are added dropwise in succession. The precipitate is filtered off with suction and washed with tetrahydrofuran. The filtrate is concentrated and the residue is distilled.
Yield: 2.2 g, content: 92 % (determined by gas chromatography) Boiling point: 70°/0.2 mbar Example C 1 7-Methyl-4-methylamino-1 , 3 , 3a, 4 , 7 , 7a-hexahvdro-isoindole HNCH Analogously to Example A, method I, 21.9 g (0.12 mol) of 1- ( tert . -butyloxycarbonylamino ) -1 , 3-pentadiene are reacted with 20.3 g (0.12 mol) of N-trimethylsilyl-maleimide and the product is then reduced with 15.2 g (0.4 mol) of lithium aluminium hydride. The crude product is recrystallised from tetrahydrofuran.
Yield: 6.2 g, melting point: 106 - 108°C.
Example D 6-Methyl-4-methylamino-l , 3 ,3a ,4,7, 7a-hexahvdro-isoindole a ) 4- ( tert . -Butyloxycarbonylamino ) -1 , 3-dioxo-6-methyl- 1/3,33,4,7, 7a-hexahydro-isoindole Boc 1-tert . -Butyloxycarbonylamino-3-methyl-l , 3-butadiene is reacted in dioxane in accordance with Example A/method Ila.
Melting point: 135 °C b) 6-Methyl-4-methylamino-l, 3 , 3a, 4 , 7 , 7a-hexahydro- isoindole Analogously to Example B, 5.6 g (20 mmol) of the product from Example Ma) are heated under reflux with 2.2 g (60 mmol) of lithium aluminium hydride in 60 ml of tetrahydrofuran for 15 hours. Working up by distillation gives 1.2 g of the product of boiling point 68-71°C/0.2-0.3 mbar.
Example E 4-Amino-7-methyl-l , 3 , 3a , 4 , 7 , 7a-hexahydro-isoindole CH3 a ) 4- ( tert . -Butyloxycarbonylamino ) -1 , 3-dioxo-7-methyl- 1 , 3 , 3a, 4 , 7 , 7a-hexahydro-isoindole CH3 0 1-tert . -Butyloxycarbonylamino-1 , 3-pentadiene is employed in accordance with Example A/method Ila and the reaction product is recrystallised from dioxane. Yield: 79 % Melting point: 208-211°C 4-Amino-7-methyl-l , 3 , 3a , 4 , 7 , 7a-hexahydro-isoindole The product from Example Na) is employed in accordance with Example B to give the free amine as an oil of boiling point 83-92 eC/0.1 mbar, which crystallises on standing-Content: 90 % pure (according to the gas chromato-gram)

Claims (2)

Patent Claims:
1. Substituted 4-amino- l,3,3a,4,7,7a-hexahydroisoindoles of the formula ^ in which R and R' denote hydrogen or methyl.
2. A compound according to claim 1 , substantially as described and exemplified herein. For the Applicants, DR. REINHOLD COHN AND PARTNERS
IL11665692A 1991-06-22 1992-06-19 4-Amino-1, 3, 3a, 4, 7, 7a- hexahydroisoindole compounds IL116656A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4120646A DE4120646A1 (en) 1991-06-22 1991-06-22 7-ISOINDOLINYL-CHINOLONE AND NAPHTHYRIDONE CARBONIC ACID DERIVATIVES
IL10226192A IL102261A (en) 1991-06-22 1992-06-19 7-isoindolinyl-quinolone- and -naphthridonecarboxylic acid derivatives their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
IL116656A0 IL116656A0 (en) 1996-05-14
IL116656A true IL116656A (en) 1996-10-31

Family

ID=25904780

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11665692A IL116656A (en) 1991-06-22 1992-06-19 4-Amino-1, 3, 3a, 4, 7, 7a- hexahydroisoindole compounds

Country Status (1)

Country Link
IL (1) IL116656A (en)

Also Published As

Publication number Publication date
IL116656A0 (en) 1996-05-14

Similar Documents

Publication Publication Date Title
EP0061333B1 (en) 9-(2-(3-indolyl)ethyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones
SK283897B6 (en) Process for preparing sildenafil
WO2012029836A1 (en) Method for producing 1-triazole-2-butanol derivative
US20110245506A1 (en) Process for Manufacturing Substituted 5-Methoxymethylpyridine-2,3-Dicarboxylic Acid Derivatives
CA1081242A (en) Alkylated hydroxylamines
US7220863B2 (en) Process for preparing 2-aminopyridine derivatives
IL116656A (en) 4-Amino-1, 3, 3a, 4, 7, 7a- hexahydroisoindole compounds
US4634700A (en) 1,3-dioxolanyl derivatives, a process for their preparation, their use and pharmaceutical preparations containing these compounds
US4424360A (en) Process for the preparation of fused 1,2,3-triazoles
KR100656636B1 (en) Process for the preparation of 6-methyl-2-4-methyl-phenyl-imidazo[1,2-a]pyridine-3-n,n-dimethyl-acetamide and intermediates
US5155257A (en) Process for the preparation of acylaminomethanephosphonic acids
JPH0458468B2 (en)
EP0388620B1 (en) Process for the preparation of o-carboxypyridyl- and o-carboxyquinolylimidazolinones
JP4433365B2 (en) Process for producing 4- (2-methyl-1-imidazolyl) -2,2-diphenylbutanamide
JP3924795B2 (en) Process for producing 2-substituted-5-chloroimidazole-4-carbaldehyde
US6774239B2 (en) Process for the preparation of N,N′-carbonyldiazoles and azolide salts
NO147838B (en) INTERMEDIATE FOR USE IN PREPARATION OF THE HYPOTENSIVE AGENT 2- (4- (2-FUROYL) PIPERAZIN-1-YL) -4-AMINO-6,7-DIMETOXYKINAZOLINE
CA2234518C (en) Process for preparing substituted oxadiazolones
US4870189A (en) Process for synthesis of azetidine and novel intermediates therefor
EP0519083A1 (en) Process for producing hexahydropyridazine-1,2-dicarboxylic acid derivative
CA1103252A (en) Process for the preparation of pyridinecarboxylic acid piperazides
US3450709A (en) Process for the preparation of ring-substituted 2-aminoimidazoles
JP3735200B2 (en) Method for producing fluorine-substituted phenylpiperidine compound
US4966979A (en) Process for synthesis of azetidine and novel intermediates therefor
US3503972A (en) Alkyl n-amidino (or guanidino)-pyrazinimidates

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees